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Inhibitors of inflammation and endogenous
surfactant pool size as modulators of lung injury
with initiation of ventilation in preterm sheep
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Alan H Jobe1,2
Abstract
Background: Increased pro-inflammatory cytokines in tracheal aspirates correlate with the development of BPD in
preterm infants. Ventilation of preterm lambs increases pro-inflammatory cytokines and causes lung inflammation.
Objective: We tested the hypothesis that selective inhibitors of pro-inflammatory signaling would decrease lung
inflammation induced by ventilation in preterm newborn lambs. We also examined if the variability in injury
response was explained by variations in the endogenous surfactant pool size.
Methods: Date-mated preterm lambs (n = 28) were operatively delivered and mechanically ventilated to cause
lung injury (tidal volume escalation to 15 mL/kg by 15 min at age). The lambs then were ventilated with 8 mL/kg
tidal volume for 1 h 45 min. Groups of animals randomly received specific inhibitors for IL-8, IL-1, or NF-B.
Unventilated lambs (n = 7) were the controls. Bronchoalveolar lavage fluid (BALF) and lung samples were used to
quantify inflammation. Saturated phosphatidylcholine (Sat PC) was measured in BALF fluid and the data were
stratified based on a level of 5 μmol/kg (~8 mg/kg surfactant).
Results: The inhibitors did not decrease the cytokine levels or inflammatory response. The inflammation increased
as Sat PC pool size in BALF decreased. Ventilated lambs with a Sat PC level > 5 μmol/kg had significantly
decreased markers of injury and lung inflammation compared with those lambs with < 5 μmol/kg.
Conclusion: Lung injury caused by high tidal volumes at birth were decreased when endogenous surfactant pool
sizes were larger. Attempts to decrease inflammation by blocking IL-8, IL-1 or NF-B were unsuccessful.
Introduction
Ventilation of preterm newborn lambs initiates inflam-
mation in the lungs [1,2]. Like preterm sheep, ventilated
very low birth weight (VLBW) infants have increased
concentrations of the pro-inflammatory cytokines IL-8,
IL-1b, IL-6, and MCP-1 in tracheal aspirates and these
increased levels correlate with an increased risk of
bronchopulmonary dysplasia (BPD) [3-5]. Ventilation of
preterm infants with moderate respiratory distress
increased plasma levels of IL-1b, IL-8 and TNF-a and
decreased levels of the anti-inflammatory cytokine IL-10
[6]. Surfactant is the major variable determining the
compliance of the preterm lung [7], and surfactant treat-
ment will decrease lung injury [8]. However the initia-
tion of ventilation at birth is a unique situation because
the airways initially are airless and fluid filled, and with-
out labor, little surfactant will have been secreted into
the fetal lung fluid. The initial ventilation of the preterm
lung will occur before much of the endogenous surfac-
tant is secreted [9], potentially increasing the risk of
injury in a lung that might be protected by surfactant.
The initiation of ventilation at birth stretches the air-
ways and triggers early growth response protein 1
(Egr-1) activation [10]. The pro-inflammatory cascade
from Egr-1 signals through NF-B to increase cytokines
and chemokines [1,10].
At a given preterm gestational age, infants have vari-
able lung maturation because of the abnormalities
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associated with the preterm delivery. An argument for
allowing the infant to transition to air breathing with
continuous positive airway pressure (CPAP) is that
uncontrolled high tidal volume ventilation can be
avoided [11]. However, many infants will require ventila-
tion to achieve respiratory transition [12]. The variability
in lung function in experimental animals at delivery is
less than in humans because the pregnancies are normal
and the deliveries are carefully controlled. However, in
sheep fetal lung maturation is rapidly changing between
128 and 136 days gestation [13]. We used a standardized
15 min escalating tidal volume injury maneuver in pre-
term sheep delivered at 133-134 d gestation to test if
inhibitors of IL-8, IL-1, or NF-B would decrease injury
responses. We used well described early response genes
(HSP70, Egr-1) and acute phase cytokines (IL-1b, IL-6,
IL-8, MCP-1), as well as inflammatory cells, to quantify
the lung injury. We also evaluated the endogenous sur-
factant pool size to test how this variability modulated
the standardized stretch injury.
Methods
The investigations were approved by the Animal Ethics
Committees of the University of Western Australia and
Cincinnati Children’s Hospital Medical Center.
Ventilation protocol
Ewes at 133 d to 134 d gestation were anesthetized prior
to operative delivery of lambs [2]. Following externaliza-
tion of the head, an endotracheal tube was secured sur-
gically [14]. After delivery, lambs were weighed and
ventilated with heated and humidified gas with FiO2 of
0.4, rate 40 breaths/min, and inspiration time of 0.7 sec
(Bournes BP200) without surfactant treatment. Lambs
received ventilation without PEEP and with tidal volume
(VT) targets of 8-10 mL/kg at 5 min, 12 mL/kg at 10
min, and 15 mL/kg by 15 min, followed by 1 h 45 min
ventilation with a PEEP 5 cmH20 and a target PaCO2 at
50-60 mmHg. The upper limits were 40 cmH2O for PIP
and 10 mL/kg for VT. VT values were measured con-
tinuously with Florian Respiratory Monitors (Acutronic
Medical Systems, Switzerland). FiO2 was adjusted to
maintain an oxyhemoglobin saturation between 88-95%.
The ventilated lambs had umbilical arterial and venous
catheters placed, and were anesthetized with Remifenta-
nil and Propofol [14]. The animals received a FiO2 of
1.0 for 3 minutes prior to receiving a lethal dose of
intravenous pentobarbital (100 mg/kg) at 2 h after birth.
Unventilated controls were euthanized prior to delivery.
Treatment with inhibitors
Lambs were randomized to selected inhibitors of inflam-
mation (n = 7 animals/group) given prior to delivery
and prior to initiating high VT ventilation. Lambs were
randomized to: 1) No inhibitor - received the VT injury
maneuver followed by ventilation only, 2) a NF-B Inhi-
bitor: Parthenolide 5 mg IV and 5 mg given intratrache-
ally, mixed with the fetal lung fluid (Sigma, St. Louis,
MO), 3) an IL-8 inhibitor: nicotinanilide thioglycolate
methyl ester (NTME) 10 mg IV (Synthrix Biosystems,
Auburn, WA), 4) the IL-1 receptor antagonist: Anikinra
at doses of 100 mg IV and 100 mg intratracheally
(Amgen, Inc., Thousand Oaks, CA), or 5) unventilated
controls. Doses and routes of administration for this
pilot study were determined from prior experiments
[15-17].
Lung Processing and Analysis
Bronchoalveolar lavage fluid (BALF) of the left lung was
used to determine total protein content [18], saturated
phosphatidylcholine (Sat PC) and differential cell counts
after cytospins [19]. Sat PC was recovered after treat-
ment of organic solvet extracts of the BALF with
osmium tetroxide by alumina column chromatography
and quantified by phosphorus assay [20]. Tissue from
the lung were snap frozen. Total RNA was isolated
using a modified Chomzynski method, and 10 μg of
total RNA was used for IL-1b, IL-6, and IL-8 RNAse
protection assays [21,22]. The right upper lobe was
inflation fixed at 30 cmH20 with 10% formalin [23], and
tissue sections were used for injury scores [1]. MCP-1
protein from BALF was analyzed by sandwich ELISA
using anti-ovine MCP-1 antibodies [24]. Immunostain-
ing protocols used paraffin sections (5 μm, transverse)
of formalin fixed tissues with anti-human Egr-1 1:250
dilution (Santa Cruz, USA) or anti-ovine MCP-1 1:300
(internally produced) [1,2]. For HSP70 mRNA identifica-
tion in situ, digoxigenin-labeled riboprobes were gener-
ated (Roche, USA) and developed per protocol [1].
Statistics
All values are expressed as means ± SEM. Comparisons
between intervention groups were made with two-tailed
Mann-Whitney nonparametric tests, Welch t-tests, or
ANOVA where appropriate. Significance was accepted
at p < 0.05.
Results
All 28 lambs survived the 2 h ventilation period. There
were no differences between cord blood gas measure-
ments, birth weights, or gender between the groups. All
animals achieved the VT goal of 15 mL/kg by 15 min
and animals had similar VT ventilation throughout the 2
h study (Table 1). All ventilated lambs had increased
BAL inflammatory cells, total protein, and MCP-1 pro-
tein compared with unventilated controls. There were
no differences in the cytokine mRNA levels for IL-1b,
IL-6 or IL-8 between the untreated or the inhibitor
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treatment groups. The lambs at this gestational age had
large differences in surfactant pool size as measured by
Sat PC in the BALF. The wide variances for cytokine
mRNA within each treatment group correlated with the
variation of Sat PC pool sizes (Figure 1). When analyzed
in this way, the inhibitors had no effect on the injury
within the limits of group sizes of 7 animals.
Lambs then were stratified into two groups based on
the graphical presentations noted in Figure 1 into those
with Sat PC levels < 5 μmol/kg in BAL (n = 18) and
those with levels > 5 μmol/kg in BAL (n = 10). Unventi-
lated control lambs had a Sat PC level of 2.0 ± 0.5
μmol/kg. All lambs had less Sat PC than the normal
levels of approximately 65 μmol/kg reported for term
lambs [25]. There were no differences in birth weight,
gestational age, or gender ratio between lambs with Sat
PC values greater or less than 5 μmol/kg (Table 2). The
differences in Sat PC measured at 2 h did not signifi-
cantly change the dynamic compliance during the 15
min VT injury maneuver (Table 2). Although no signifi-
cant differences in VT or compliance were apparent dur-
ing the 15 min stretch injury or at 30 min, lambs with
Sat PC levels > 5 μmol/kg had improved ventilation,
oxygenation, and compliances when ventilated with
lower VT for the last hour of mechanical ventilation
(Figure 2). Lambs with Sat PC < 5 μmol/kg required a
FiO2 between 0.40 to 0.53 to maintain oxygen satura-
tions, whereas the lambs with higher Sat PC levels
required a FiO2 of only 0.25 to 0.39.
All markers of lung injury were higher in animals with
Sat PC levels below 5 μmol/kg in BALF than in the ani-
mals with higher Sat PC levels (Table 2). All ventilated
animals had airway injury with sloughing of epithelium
and inflammatory cells. Injury scoring between groups
was higher in low Sat PC animals (Table 2). In situ loca-
lization of HSP70 mRNA demonstrated loss of the
mRNA from bronchial epithelial cells in the ventilated
animals compared with the unventilated controls and
increased HSP70 mRNA in the smooth muscle sur-
rounding the airways with ventilation (Figure 3A-C).
There were no differences in HSP70 mRNA expression,
representing similar airway over-expansion during venti-
lation. Early growth response protein 1 (Egr-1) sur-
rounded the mesenchyme of the larger airways and was
Table 1 Animals grouped by inhibitor treatments
N BW VT
15 min
VT
2 h
BALF Protein BALF Inflammatory cells BALF
MCP-1
IL-1b
mRNA
IL-6
mRNA
IL-8
mRNA
mL/kg mg/kg x106/kg ng/mL fold increase
Controls 7 3.2 ± 0.1 None 23 ± 6 1.2 ± 1.0 0.6 ± 0.6 1 ± 0.2 1 ± 0.2 1 ± 0.1
No Inhibitor 7 3.5 ± 0.2 15.7 ± 0.5 8.6 ± 0.8 82 ± 11* 81 ± 23* 28 ± 7* 16 ± 4* 43 ± 14* 28 ± 12*
NF-B Inhbitor 7 3.6 ± 0.1 16.2 ± 1.1 9.3 ± 0.4 92 ± 18* 101 ± 34* 44 ± 10* 21 ± 4* 53 ± 11* 24 ± 5*
IL-8 Inhibitor 7 3.3 ± 0.1 15.5 ± 1.4 10.9 ± 0.9 72 ± 11* 63 ± 29* 32 ± 13* 14 ± 5* 20 ± 7* 12 ± 3*
IL-1 Inhibitor 7 3.6 ± 0.2 16.4 ± 0.7 9.6 ± 0.7 72 ± 18* 33 ± 11* 13 ± 7* 7 ± 2* 23 ± 15* 9 ± 3*
BALF = bronchoalveolar lavage fluid, BW = birth weight * p < 0.05 vs Controls.
Figure 1 Relationship of pro-inflammatory cytokine mRNA and Sat PC in BALF. Scatter plots for cytokines based on Sat PC levels in BALF
of individual lambs show decreased injury in lambs with Sat PC level > 5 μmol/kg. Cytokine mRNA levels were determined by RNase protection
assays with L32 as an internal loading control. Values are expressed as fold increase of mRNA over unventilated controls, whose level was set to
equal 1. ◆ No inhibitor ■ IL-1 inhibitor, ▲ NF-B inhibitor ● IL-8 inhibitor.
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expressed in the medium sized conducting airways (Fig-
ure 3D-F). Egr-1 staining tended to be higher (175 vs
128 cells/high power field) in animals with lower Sat PC
levels (Figure 3D-F). MCP-1 protein was localized to
similar regions, but with more variation within each
group (Figure 3G-I). MCP-1 protein levels in the BAL
were increased 5 fold in animals with Sat PC less than 5
μmol/kg (Table 2).
Discussion
Using a premature sheep model, we mimicked high tidal
volume resuscitation with subsequent ventilation to test
if several inhibitors of pro-inflammatory mediators
would decrease injury. The preterm lambs had lung
inflammation to 15 minutes of escalating VT ventilation
and the subsequent ventilation. Although the study was
designed to cause lung injury, the current preterm
lambs had a similar magnitude increase in inflammatory
markers to lambs ventilated with a tidal volume of 8
mL/kg and PEEP of 5 cmH20 [14]. We did not find dif-
ferences in respiratory physiology or markers of injury
between the ventilation only animals and those treated
with inhibitors of IL-1, IL-8, or NF-B, but there was
variable injury within each treatment group. We took
advantage of this variable injury to demonstrate that the
amount of Sat PC in the BALF at autopsy was asso-
ciated with the amount of lung inflammation and injury.
There appears to be a critical surfactant threshold
(approximately 5 μmol/kg in preterm lambs) for partial
protection of the preterm lung from injury and inflam-
mation caused by initiation of ventilation with high VT.
However the surfactant pool size measured at 2 h did
not correlate with the compliances of the animals during
the initial 15 min ventilation injury.
In these studies, we attempted to inhibit important
pro-inflammatory mediators of early lung injury
response. Since many of the pro-inflammatory cytokines
are transcribed after nuclear translocation of NF-B, we
used both IV and intra-tracheal parthenolide to block
NF-kB activation in 7 lambs. Parthenolide is a sesquiter-
pene lactone derived from the plant Feverfew which
may block NF-B activity through inhibition of I-B
kinase activity [26]. The NF-kB system is active in pre-
term sheep and responds to intra-amniotic LPS [27].
Mice also have NF-B activity by mid-gestation which
increases near the end of gestation and in early post-
natal life [28]. Mice ventilated with large VT had NF-B
activation and cytokine production similar to mice
exposed to LPS, but the cytokine increases were blocked
by pretreatment with dexamthasone [29]. Our previous
attempts to block lung inflammation with high dose
dexamethasone or hydrocortisone were unsuccessful in
the setting of initiation of ventilation in preterm sheep
[2]. In a newborn piglet model of RDS, animals receiv-
ing a NF-B inhibitor had no improvement over con-
trols [30]. Inhibition of NF-B in mice exposed to high
VT ventilation and hyperoxia blocked the additive effect
of hyperoxia on volutrauma suggesting differing roles of
NF-B in stretch injury verses oxidative injury [31]. In
these three animal models of acute respiratory failure
and in these preterm lambs, blockade of NF-B was
unable to prevent inflammation from mechanical
ventilation.
We also attempted to block two of the major pro-
inflammatory cytokines that are increased with high VT
ventilation. We used recombinant human IL-1ra (Ani-
kinra) to block IL-1 signaling. rhIL-RA is used clinically
for treatment of a variety of inflammatory diseases
and mutations ofIL-1ra result in severe systemic
Table 2 Saturated phosphatidylcholine levels and indices
of injury
Sat PC <
5
(n = 18)
Sat PC >
5
(n = 10)
p value
Description of Animals
Birth weight (kg) 3.5 ± 0.1 3.5 ± 0.1 = 1
Gender (male:female) 10:8 6:4 = 1
Gestational Age (days) 133.1 133.1 = 1
BAL Sat PC (μmol/kg) 2.5 ± 0.3 10.6 ±
1.4*
< 0.001
VT and Compliance
VT/kg at 5 min (mL/kg) 10.2 ± 0.6 10.8 ± 0.7 = 1
VT/kg at 10 min (mL/kg) 14.4 ± 0.4 14.3 ± 0.5 = 1
VT/kg at 15 min (mL/kg) 15.6 ± 0.6 16.5 ± 0.5 = 1
Compliance 5 min (mL/cmH20/
kg)
0.28 ±
0.02
0.31 ±
0.03
= 0.50
Compliance 10 min (mL/cmH20/
kg)
0.34 ±
0.01
0.39 ±
0.02
= 0.11
Compliance 15 min (mL/cmH20/
kg)
0.36 ±
0.02
0.42 ±
0.02
= 0.06
BAL Fluid
Protein (mg/kg) 94.4 ± 9.0 52.4 ± 7.8 < 0.002
Neutrophils (x106/kg) 74.2 ± 1.8 16.2 ± 9.6 < 0.01
Monocytes (x106/kg) 12.3 ± 2.9 8.9 ± 1.3 = 0.49
MCP-1 protein (ng/ml) 42.1 ± 5.6 7.2 ± 3.2 <
0.0001
Lung Tissue (mRNA fold increase)
IL-1b 19.2 ± 2.3 6.2 ± 1.3 <
0.0001
IL-6 49.9 ± 8.0 7.2 ± 1.8 < 0.001
IL-8 24.8 ± 4.8 6.7 ± 0.8 <
0.0001
Injury Scores
(Out of 8 total points) 4.8 ± 0.2 3.0 ± 0.5 = 0.02
VT = tidal volume, BAL = bronchoalveolar lavage fluid, Sat PC = saturated
phosphatidylchloline.
BW = birth weight, Compliance = (VT/kg)/(PIP-PEEP) * p < 0.05 vs Sat PC < 5.
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Figure 2 Compliance, ventilation efficiency index, and oxygenation. Lambs with Sat PC < 5 μmol/kg had decreased dynamic compliance
values for the last hour of ventilation. Ventilation efficiency index decreased and oxygenation index increased in lambs with Sat PC < 5 μmol/kg,
indicating decreased gas exchange over time. Oxygenation index at 2 h was measured on an FiO2 of 1.0. Compliance = VT /pressure, Ventilation
Efficiency Index = 3800/(PIP•rate•PaCO2). Oxgenation index = (FiO2•Mean Airway pressure)/PaO2. ● Sat PC > 5 μmol/kg ■ Sat PC < 5 μmol/kg * p
< 0.05 vs Sat PC < 5 μmol/kg.
Figure 3 Localization of HSP70 mRNA, Egr-1 protein and MCP-1 protein. HSP70 in situ localization demonstrates signal in bronchial
epithelium in controls (A), which is lost in ventilate lambs (B, C). Induction of HSP70 mRNA in smooth muscle surrounding airways is seen in
lambs with < 5 μmol/kg Sat PC (B) and lambs with >5 μmol/kg (C). Egr-1 protein is not in airways of control lambs (D) but Egr-1 protein
staining is qualitatively increased in lambs ventilated with < 5 μmol/kg Sat PC (E) verses lambs with > 5 μmol/kg (F). Compared to MCP-1 in
controls (G), MCP-1 protein is localized to the mesenchyme surrounding the medium sized airways and to the inflammatory cells in lambs
ventilated with < 5 μmol/kg Sat PC (H) with minimal staining in animals with > 5 μmol/kg (I). Scale bar = 50 μm, insert 25 μm.
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inflammation in early childhood [32]. We previously
demonstrated that rhIL-1ra completely blocked lung
inflammation from recombinant sheep IL-1 and
decreased, but did not eliminate, the inflammatory
response to LPS [16]. When adjusted for the amount of
Sat PC in BAL, the IL-1 receptor blocker did not
decrease lung injury in these lambs. We also tested
nicotinanilide thioglycolate methyl ester (NTME), a
CXCR2 inhibitor, to block IL-8 signaling. We previously
demonstrated that NTME blocked recombinant ovine
IL-8, but did not inhibitLPS induced lung inflammation
in preterm sheep [15]. We found no decrease in ventila-
tion mediated lung injury for this IL-8 inhibitor.
Although drug levels were not measured in this study,
we previously measured bio-availability of Anikinra and
NTME in sheep [15,16]. Based on our previous results,
the dosage used in the present study should have
blocked IL-1 and IL-8 signaling. These studies, in
combination with our previous study with postnatal
corticosteroid treatment, suggest that blockade of pro-
inflammatory responses to the initiation of ventilation of
preterm infants will not be accomplished easily.
Previous preterm animal studies demonstrated
improved ventilation with increasing endogenous sur-
factant pool sizes [7,19]. Base on the observation that
animals with lower Sat PC levels had exponentially
higher indicators of lung injury, we stratified the ani-
mals based on Sat PC level. We found animals with
Sat PC levels less than < 5 μmol/kg (about 8 mg/kg
surfactant based on assumption that Sat PC is 50% of
the surfactant lipid pool) had significantly more injury
than those with more Sat PC. These findings were
similar to our previous findings that lambs with less
than 1.9 μmol/kg Sat PC (3 mg/kg surfactant) had
high PaCO2 on CPAP, whereas lambs with more Sat
PC had normal PaCO2 levels [19]. The average surfac-
tant pool of the term newborn sheep is approximately
100 mg/kg in BALF [25]. The average surfactant pool
in group of animals with > 5 μmol/kg was about 15%
of the levels reported at term. The average Sat PC
pool for the lambs with < 5 μmol/kg was 2.5 μmol/kg,
about 1.3 fold higher than that for lambs that pre-
viously survived on CPAP [19]. This lower effective
pool size for the lambs on CPAP may result from the
lack of intentional lung injury in those animals. The
high VT and resultant lung injury should cause inhibi-
tion of endogenous surfactant pools [7]. In 1970,
Adams found surfactant pools less than 5 mg/kg in
infants who died with RDS without mechanical ventila-
tion [33]. These lambs were date-mated and the major-
ity of lambs (25/28) were 133 days gestation,
suggesting that small variations in lung maturation at
the same gestational age can affect lung injury. Small
changes in endogenous surfactant levels may have
larger effects on lung mechanics than larger surfactant
pool size increases with surfactant treatment [7].
Small increases in the endogenous surfactant pool size
could decrease the heterogeneity of lung expansion and
cause a more even distribution of VT across the regions of
the lung, and thus decrease focal injury [34]. Surfactant
decreases surface tension and maintains FRC [35]. Since
no PEEP was used during the first 15 min, the lambs with
higher Sat PC may have had reduced regions of airway
collapse. Newly secreted surfactant following birth is the
large aggregate surfactant that has the best functional
characteristics. High tidal volume ventilation can convert
surfactant from surface-active large-aggregates to less sur-
face-active surfactant forms [36] and these changes in sur-
factant forms proceed physiologic changes during
ventilation [37]. The lambs with less surfactant in BAL
may have had less functional surfactant and more surfac-
tant inhibition, although these variables were not mea-
sured [38]. The induction of HSP70 in the smooth muscle
of the airways was not changed by the amount of Sat PC,
demonstrating an airway injury response with ventilation
in all groups [1]. Our current analysis of injury based on
surfactant pool size stresses the importance of the endo-
genous surfactant pool size on lung injury induced by the
initiation of ventilation at birth.
A limitation of our study is the sample size (n = 7 to 8)
for each intervention group. The study is thus powered
to demonstrate only large differences between inhibitor
groups and small differences from the inhibitors would
not be detected. This variability in injury response is a
limitation to studies with large animals. Another limita-
tion of the study is the use of Sat PC levels after 2 hours
of ventilation as a marker for endogenous surfactant pool
size at birth. Surfactant is secreted into the airspace with
the initiation of ventilation [9], such the pool size during
the 15 min of tidal volume escalation would be smaller
than the values measured at 2 hr. A final limitation of
large animal studies is the difficulty in proving causality.
We simply can correlate the results that lambs with
increased surfactant pool sizes had decreased injury, as
was seen with premature rabbits [13].
Conclusions
Small changes in the surfactant pool size correlated with
large differences in lung injury and inflammation. All
the preterm lambs were surfactant deficient and had
ventilator induced lung injury, but a Sat PC level of > 5
μmol/kg was sufficient to reduce the injury. Stretch
injury to preterm sheep lung activates multiple, over-
lapping acute phase response pathways, with cytokine
production and lung inflammation as potential adverse
outcomes. The lung inflammation from mechanical ven-
tilation will likely not be prevented by the inhibition of
any particular pro-inflammatory cytokine or by a more
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global inhibition with postnatal steroids [2]. While sur-
factant pools may serve as a biomarker for eventual
lung injury from mechanical ventilation, there is no
practical way to measure the pool size prior to or
shortly after resuscitation in infants. Minor changes in
surfactant pool sizes, as demonstrated by this study, are
important for lung injury and support the use of antena-
tal steroids to increase surfactant.
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